XLRN Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Jan 1970 @ 01:00):

Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases...

Stats
Tagesvolumen	7.88M
Durchschnittsvolumen	1.27M
Marktkapitalisierung	0.00
EPS	$-1.160 ( 2021-11-04 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$2.64 (1.48%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-19	Zakrzewski Joseph S	Sell	34 499	Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	10 000	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	7 500	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	7 500	Option to Purchase Common Stock
2021-11-19	Zakrzewski Joseph S	Sell	10 000	Option to Purchase Common Stock

INSIDER POWER
0.00
Last 100 transactions
Buy: 155 406 \| Sell: 743 673

Volumen Korrelation

Lang: 0.40 (neutral)

Kurz: 0.62 (weak)

Signal:(71.182) Neutral

Acceleron Pharma Inc Korrelation

10 Am meisten positiv korreliert
APAC	0.971
THCPU	0.97
WTMA	0.97
ALGN	0.966
CRUS	0.963
ALGM	0.961
ATRS	0.961
IQ	0.96
NVAC	0.96
BLDR	0.959

10 Am meisten negativ korreliert
NAKD	-0.958
PROC	-0.953
MTEX	-0.949
AHPI	-0.949
GRIN	-0.946
TRIT	-0.94
PIII	-0.938
LCAP	-0.935
CYTO	-0.935
LAWS	-0.934

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Acceleron Pharma Inc Korrelation - Währung/Rohstoff

-0.74
( moderate negative )

-0.78
( moderate negative )

0.52
( weak )

-0.74
( moderate negative )

0.05
( neutral )

0.79
( moderate )

Acceleron Pharma Inc Finanzdaten

Annual	2020
Umsatz:	$92.52M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-2.92

FY	2020
Umsatz:	$92.52M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-2.92

FY	2019
Umsatz:	$73.99M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-2.38

FY	2018
Umsatz:	$13.99M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-2.59

Financial Reports:

No articles found.

Acceleron Pharma Inc

Acceleron Pharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. It offers luspatercept-aamt for the treatment of anemia in adult patients with beta-thalassemia under the REBLOZYL name. The company also develops luspatercept-aamt for the treatment of myelodysplastic syndromes and myelofibrosis; Sotatercept for the treatment of patients with pulmonary arterial hypertension; and ACE-083, a neuromuscular candidate that is in Phase II clinical trials for the treatment of patients with Charcot-Marie-Tooth disease. In addition, it has a collaboration, license, and option agreement with Celgene Corporation; and collaboration and license agreement with Fulcrum Therapeutics, Inc. to identify small molecules designed to modulate specific pathways associated with a targeted indication within the pulmonary disease space. The company was formerly known as Phoenix Pharma, Inc. Acceleron Pharma Inc. was founded in 2003 and is headquartered in Cambridge, Massachusetts.